Top Markets
Coin of the day
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
株式のランク #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
株価
$3.01
最終同期: 2024-04-12
時価総額
$104.64M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Cyteir Therapeutics, Inc. (CYT)

カテゴリー

Cyteir Therapeutics, Inc.(CYT)の株価履歴
終値の最高値: $3.01 (2024-04-01)

終値の最安値: $18.73 (2021-06-01)
Cyteir Therapeutics, Inc. の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2024 -2.00%
2023 125.69%
2022 -88.47%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH